Dominari Holdings Provides Update on Share Repurchase Program
Dominari Holdings Inc. (Nasdaq: DOMH) announced an update on its $2 million share repurchase program initiated on December 5, 2022. As of February 16, 2023, the Company repurchased 5,000 shares at $3.8475 each. The repurchase will continue based on market conditions and regulatory limits. Dominari is transitioning from its focus on therapeutics to fintech and financial services following an acquisition. The subsidiary, Dominari Financial Inc., will manage these new operations, while Aikido Labs, LLC will continue developing therapeutics.
- The share repurchase program demonstrates management's confidence in the stock's value, potentially enhancing shareholder value.
- Transitioning into fintech and financial services opens new revenue streams for the company.
- The share repurchase could strain cash reserves, impacting other operational investments.
The Company reported that on
Additional shares may be repurchased from time to time in open market transactions, or other means in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and Rule 10b -18 of the Exchange Act. The timing, number of shares repurchased, and prices paid for the stock under this program will depend on general business and market conditions as well as corporate and regulatory limitations, including blackout period restrictions.
About
Forward-Looking Statements
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the
Contact:
Investor Relations:
Hayden IR
Phone: (646) 536-7331
Email: brett@haydenir.com
www.haydenir.com
Phone: 212-745-1373
Email: investorrelations@aikidopharma.com
www.aikidopharma.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/dominari-holdings-provides-update-on-share-repurchase-program-301749369.html
SOURCE
FAQ
What is the purpose of Dominari Holdings' share repurchase program?
How many shares did Dominari Holdings repurchase recently?
What does the transition to fintech mean for Dominari Holdings?